Growth Metrics

Palvella Therapeutics (PVLA) Free Cash Flow Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 60.84%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 88.70%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -15.72%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 66.37%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.98%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 137.65%
10 Palvella Therapeutics 1.47 Bn 1.21 Bn - -61.05%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -61.05%
Dec 31, 2025 8.77%
Sep 30, 2025 -187.38%
Jun 30, 2025 -238.86%
Mar 31, 2025 -514.16%
Dec 31, 2024 -126.14%
Sep 30, 2024 72.11%
Jun 30, 2024 88.09%
Mar 31, 2024 90.02%
Dec 31, 2023 247.97%
Sep 30, 2023 -11.81%
Jun 30, 2023 12.02%
Mar 31, 2023 51.86%
Dec 31, 2022 -17.24%
Sep 30, 2022 38.19%
Jun 30, 2022 -151.54%
Mar 31, 2022 -88.57%
Dec 31, 2021 15.02%
Sep 30, 2021 -111.40%
Jun 30, 2021 373.80%
Mar 31, 2021 28.68%
Dec 31, 2020 7.62%
Sep 30, 2020 47.76%
Jun 30, 2020 7.09%
Mar 31, 2020 -12.01%
Dec 31, 2019 -57.44%
Sep 30, 2019 12.26%
Jun 30, 2019 -24.34%
Mar 31, 2019 -149.24%
Dec 31, 2018 -74.55%
Sep 30, 2018 -142.06%
Jun 30, 2018 -30.58%
Mar 31, 2018 20.84%
Dec 31, 2017 20.86%
Sep 30, 2017 1,025.14%
Jun 30, 2017 -16.51%
Mar 31, 2017 1,206.62%
Dec 31, 2016 -145.00%
Sep 30, 2016 -1.11%
Jun 30, 2016 -97.84%
Mar 31, 2016 153.90%
Sep 30, 2015 -26,713.92%
Jun 30, 2015 8.64%
Mar 31, 2015 -764.67%
Sep 30, 2014 -208.47%
Jun 30, 2014 -1,245,120.07%